共 33 条
- [21] BIODEGRADABLE POLYMER DRUG-ELUTING STENTS VERSUS DURABLE POLYMER SIROLIMUS-ELUTING STENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA FROM THE ISAR-TEST 3, ISAR-TEST 4, AND LEADERS RANDOMIZED TRIALS AT 4 YEARS JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E285 - E285
- [22] Safety of 3-Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus-Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART-CHOICE Trial JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (01): : 1 - 9
- [26] Clinical outcomes three-year after revascularization with biodegradable polymer stents: ultrathin-strut sirolimus-eluting stent versus biolimus-eluting stent: from the Scandinavian organization for randomized trials with clinical outcome VII trial CORONARY ARTERY DISEASE, 2020, 31 (06) : 485 - 492
- [29] Outcome of percutaneous coronary intervention using ultrathin- strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2023, 13 (04) : 673 - +
- [30] Safety of 3-Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus-Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART-CHOICE Trial (vol 10, e018366, 2021) JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (06):